Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

Strategies that employ HSV amplicon vectors in the prevention and/or amelioration of pathogenic states afflicting the central nervous system (CNS) have been extensively documented in preclinical disease models. The versatility of the HSV amplicon platform allows for the implementation of therapeutic approaches that require expression of genes exhibiting neuroprotective or neuroplastic activities, or even applications that necessitate the elaboration of antigenspecific immune responses to pathogenic proteins/structures harbored within the CNS. This discourse highlights the successes and challenges encountered using HSV amplicon vectors as tools for the dissection of neural network function and as therapeutics directed against a variety of neurologic disorders.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/156652306777592045
2006-06-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/156652306777592045
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test